News Release

July 7, 2010

Contact: Chris DeFrancesco, 860-679-3914
e-mail: cdefrancesco@uchc.edu

UConn Health Center Adds Oral and Maxillofacial Surgeon

Dr. Liansheng Song Joins Center for Implant and Reconstructive Dentistry

FARMINGTON, CONN. Dr. Liansheng Song, an oral and maxillofacial surgeon, is seeing patients at the Center for Implant and Reconstructive Dentistry at the University of Connecticut Health Center.

Song brings more than 20 years of clinical, academic and research experience to the UConn Health Center. His trained at the University of Rochester, the University of Washington, Staten Island University Hospital, the University of Medicine and Dentistry of New Jersey, and the Medical College of Wisconsin. He is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American Association of Oral and Maxillofacial Surgeons.

Song is a resident of Farmington.

Photo: http://today.uchc.edu/images/news/song.jpg
Caption: Dr. Liansheng Song has joined the UConn Health Center and is seeing patients at the Center for Implant and Reconstructive Dentistry.

More information about the Center for Implant and Reconstructive Dentistry, a division of the New England Musculoskeletal Institute, is available at http://dentalimplants.uchc.edu. To schedule an appointment, call 860-679-7600.

UConn Health includes the schools of medicine and dental medicine, the UConn Medical Group, University Dentists, and John Dempsey Hospital. Home to Bioscience Connecticut, UConn Health pursues a mission of providing outstanding health care education in an environment of exemplary patient care, research and public service. More information about UConn Health is available at www.uchc.edu.

Note: News professionals are invited to visit the UConn Health Today news page (http://today.uchc.edu) for regularly updated news and feature stories, photos and media stories. News releases are archived at http://today.uchc.edu/newsreleases/2014. UConn Health news and information is also available on Facebook, Twitter and YouTube.